The impact of interventional cardiology for the management of adults with congenital heart defects
Authors:
- Massimo ChessaMCMassimo Chessa
- Edoardo BossoneEBEdoardo Bossone
- Mario CarminatiMCMario Carminati
- 16 January 2006
- journal article
- pediatric and-congenital-heart-disease
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 67 (2) , 258-264
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Changing practice of cardiac surgery in adult patients with congenital heart diseaseHeart, 2005
- CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defectsAmerican Heart Journal, 2004
- Multicenter USA Amplatzer Patent Ductus Arteriosus Occlusion Device TrialJACC, 2004
- Device closure of iatrogenic membranous ventricular septal defects after prosthetic aortic valve replacement using the Amplatzer membranous ventricular septal defect occluderCatheterization and Cardiovascular Interventions, 2004
- Congenital heart disease in adults: Catheterization laboratory considerationsCatheterization and Cardiovascular Interventions, 2003
- Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Initial clinical experienceCatheterization and Cardiovascular Interventions, 2002
- Myocardial infarction: redefined or reinvented?Heart, 2002
- Pulmonary artery trauma due to balloon dilation: recognition, avoidance and managementJACC, 2000
- Should atrial septal defects in adults be closed?The Annals of Thoracic Surgery, 1996
- Natural history of persistent ductus arteriosus.Heart, 1968